Cargando…
Case report of treatment experience with idursulfase beta (Hunterase) in an adolescent patient with MPS II
Mucopolysaccharidosis (MPS) II or Hunter syndrome is a chronic, progressive, multi-systemic illness associated with significant morbidity and early mortality. Available evidence in Asian populations shows that Hunter syndrome has a mean age of onset of 2 to 5 years and a life expectancy of 13 years...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432659/ https://www.ncbi.nlm.nih.gov/pubmed/28540187 http://dx.doi.org/10.1016/j.ymgmr.2017.05.002 |